<DOC>
	<DOCNO>NCT00952419</DOCNO>
	<brief_summary>The purpose study evaluate different dos Influenza A/H1N1 pandemic vaccine toddler child . Primary Objectives : - To describe immunogenicity candidate vaccine injection . - To describe safety candidate vaccine injection .</brief_summary>
	<brief_title>A Study Different Formulations A/H1N1 Pandemic Vaccine Healthy Children Aged 6 Months 9 Years</brief_title>
	<detailed_description>Participants receive two injection randomized vaccine Day 0 Day 21 , respectively .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : All subject : Provision Informed Consent Form sign subject 's parent ( ) /legal representative ( independent witness require local regulation ) . In addition , provision Assent Form sign subject age 7 9 year Subject parent/guardian able attend schedule visit comply trial procedure Subjects age 3 9 year : Healthy child age 3 9 year day inclusion Subjects age 6 35 month : Healthy infant toddler age 6 35 month day inclusion Born full term pregnancy ( ≥ 37 week ) birth weight ≥ 2.5 kg Exclusion Criteria : Participation another clinical trial investigate vaccine , drug , medical device , medical procedure 4 week precede first trial vaccination Planned participation another clinical trial present trial period Receipt vaccine 4 week precede trial vaccination Planned receipt vaccine prior Day 42 blood sample Receipt blood bloodderived product past 3 month might interfere assessment immune response Known suspect congenital acquire immunodeficiency , immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 6 month , longterm systemic corticosteroid therapy ( prednisone equivalent 2 consecutive week within past 3 month ) Selfreported seropositivity Human Immunodeficiency Virus ( HIV ) , Hepatitis B surface antigen , Hepatitis C Known systemic hypersensitivity vaccine component , history lifethreatening reaction vaccine ( ) use trial vaccine contain substance Self report thrombocytopenia contraindicating intramuscular ( IM ) vaccination Bleeding disorder receipt anticoagulants 3 week precede inclusion contraindicate IM vaccination Deprived freedom administrative court order , emergency setting , hospitalize involuntarily Chronic illness opinion investigator , stage might interfere trial conduct completion Employees investigator study center , direct involvement propose study study direction investigator study center , well family member employee investigator . Any confirm case influenza ( include swineorigin A/H1N1 Influenza ) since March 2009 Personal family history GuillainBarré syndrome Active neoplastic disease history hematologic malignancy Known seizure/epilepsy history and/or take antiseizure medication Receipt psychiatric drug . Subjects receive single antidepressant drug stable least 3 month prior enrollment , without decompensating symptom allow enroll study Febrile illness ( temperature ≥ 100.4°F [ ≥ 38.0°C ] ) moderate severe acute illness/infection ( accord investigator judgment ) day vaccination</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Pandemic Flu</keyword>
	<keyword>Swine-origin A/H1N1 Influenza</keyword>
	<keyword>Children</keyword>
</DOC>